Cargando…

RRM2 expression in different molecular subtypes of breast cancer and its prognostic significance

BACKGROUND: Breast cancer is one of the most common types of cancer. Ribonucleotide reductase (RNR) is a heterodimeric tetramer consisting of two Ribonucleoside-diphosphate reductase large subunits (RRM1) and two Ribonucleoside-diphosphate reductase small subunits (RRM2). RRM2 is the building subuni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdel-Rahman, Manar Ahmed, Mahfouz, Mena, Habashy, Hany Onsy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734361/ https://www.ncbi.nlm.nih.gov/pubmed/34986845 http://dx.doi.org/10.1186/s13000-021-01174-4

Ejemplares similares

Nuclear Factor-κB Clinical Significance in Breast Cancer: An Immunohistochemical Study
por: Al-Mutairi, Mashael Saqer, et al.
Publicado: (2022)

Expression levels of β-catenin and galectin-3 in meningioma and their effect on brain invasion and recurrence: a tissue microarray study
por: Ahmed, Rehab Allah, et al.
Publicado: (2017)

Bioinformatics analysis revealing prognostic significance of RRM2 gene in breast cancer
por: Chen, Wei-xian, et al.
Publicado: (2019)

RRM2 is a potential prognostic biomarker with functional significance in glioma
por: Sun, Hongzhi, et al.
Publicado: (2019)

The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia
por: Chatzidavid, Sevastianos, et al.
Publicado: (2023)

Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification
por: Powe, Desmond G, et al.
Publicado: (2009)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes
por: Althobiti, Maryam, et al.
Publicado: (2020)

Prognostic Significance of Interferon-γ and Its Signaling Pathway in Early Breast Cancer Depends on the Molecular Subtypes
por: Heimes, Anne-Sophie, et al.
Publicado: (2020)

Independent prognostic implications of RRM2 in lung adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2020)

The subtype‐specific molecular function of SPDEF in breast cancer and insights into prognostic significance
por: Ye, Ting, et al.
Publicado: (2021)

Significance of ERβ expression in different molecular subtypes of breast cancer
por: Guo, Liying, et al.
Publicado: (2014)

Expression of Genomic Instability-Related Molecules: Cyclin F, RRM2 and SPDL1 and Their Prognostic Significance in Pancreatic Adenocarcinoma
por: Klimaszewska-Wiśniewska, Anna, et al.
Publicado: (2021)

Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine
por: Jørgensen, Charlotte LT, et al.
Publicado: (2013)

This is how breast cancer should not be managed!
por: Monib, Sherif, et al.
Publicado: (2020)

RRM1 *151A>T, RRM1 ‐756T>C, and RRM1 ‐585T>Gis associated with increased susceptibility of lung cancer in Chinese patients
por: Xu, Xiao‐Ling, et al.
Publicado: (2016)

m(6)A levels and expression of its modification genes show significant differences in breast cancer molecular subtypes
por: Kleinbielen, Tamara, et al.
Publicado: (2022)

Prognostic Value of Clinicopathological Factors for Indonesian Breast Carcinomas of Different Molecular Subtypes
por: Widodo, Irianiwati, et al.
Publicado: (2017)

The different prognostic impact of age according to individual molecular subtypes in breast cancer
por: Kim, Nam Hee, et al.
Publicado: (2022)

HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas
por: Zhu, Huaxin, et al.
Publicado: (2023)

Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
por: Ohmura, Shunya, et al.
Publicado: (2021)

Prognostic significance of expression of epithelial-mesenchymal transition driver brachyury in breast cancer and its association with subtype and characteristics
por: Lee, Kwan Ho, et al.
Publicado: (2018)

Characterization of the microenvironment in different immune-metabolism subtypes of cervical cancer with prognostic significance
por: Lai, Wujiang, et al.
Publicado: (2023)

Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study
por: Su, Yinghao, et al.
Publicado: (2011)

Prognostic Significance of a Complete Response on Breast MRI in Patients Who Received Neoadjuvant Chemotherapy According to the Molecular Subtype
por: Ko, Eun Sook, et al.
Publicado: (2015)

The prognostic impact of age in different molecular subtypes of breast cancer: a population-based study
por: Dai, Dongjun, et al.
Publicado: (2019)

Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2017)

DUSP4 Silencing Enhances the Sensitivity of Breast Cancer Cells to Doxorubicin through the Activation of the JNK/c-Jun Signalling Pathway
por: Al-Mutairi, Mashael S., et al.
Publicado: (2022)

Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2023)

Structural study of the Fox-1 RRM protein hydration reveals a role for key water molecules in RRM-RNA recognition
por: Krepl, Miroslav, et al.
Publicado: (2017)

The prognostic value of node status in different breast cancer subtypes
por: Yang, Zheng-Jun, et al.
Publicado: (2016)

Pathway-Centric Integrative Analysis Identifies RRM2 as a Prognostic Marker in Breast Cancer Associated with Poor Survival and Tamoxifen Resistance()()()
por: Putluri, Nagireddy, et al.
Publicado: (2014)

High RRM2 expression has poor prognosis in specific types of breast cancer
por: Shi, Shen-chao, et al.
Publicado: (2022)

Screening and Identification of Key Common and Specific Genes and Their Prognostic Roles in Different Molecular Subtypes of Breast Cancer
por: Sun, Na, et al.
Publicado: (2021)

RNA recognition and self-association of CPEB4 is mediated by its tandem RRM domains
por: Schelhorn, Constanze, et al.
Publicado: (2014)

«Salivaomics» of Different Molecular Biological Subtypes of Breast Cancer
por: Bel’skaya, Lyudmila V., et al.
Publicado: (2022)

Prognostic signatures of breast cancer: Perou's molecular subtypes and Schmidt's metagenes
por: Cadenas, Cristina
Publicado: (2012)

Prognostic and immune infiltration significance of ARID1A in TCGA molecular subtypes of gastric adenocarcinoma
por: Zhang, Zhenkun, et al.
Publicado: (2023)

Prognostic Impact of BRCA1 and BRCA2 Mutations on Long-Term Survival Outcomes in Egyptian Female Breast Cancer Patients
por: AbdelHamid, Sherihan, et al.
Publicado: (2021)

Clinical outcome of brain metastases differs significantly among breast cancer subtypes
por: Oehrlich, Nadja E., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hgg8o4fj97uab2i9sbi7ct46gb